Xiaodong Wang

Director

Xiaodong Wang (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in BGNE. The largest single filing was $13.4M of ONC (38,287 sh across 8 lots, as filed), executed Sep 8.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$13.4M

shares × price, as filed

Last traded

Sep 8

Filed Sep 10

Median ADV $130.5M across their filed names

Open performance→

Volume by month

Buys $0 Sells $90.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

BGNE BGNE BGNE · 0 buys · 8 sells 8 filings ONC

BeOne Medicines AG ONC · 0 buys · 3 sells 3 filings

Recent filings

ONCSALE BeOne Medicines AG View filing → $13.4M
38,287 sh across 8 lots
Exec Sep 8
Filed Sep 10 · 4:49 PM ET ONCSALE BeOne Medicines AG View filing → $427K
1,607 sh across 2 lots
Exec Jun 24 2025
Filed Jun 25 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $10.9M
41,660 sh across 4 lots
Exec Jun 10 2025
Filed Jun 12 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $9.3M
41,560 sh across 3 lots
Exec May 13 2025
Filed May 15 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $10.0M
41,395 sh across 12 lots
Exec Apr 14 2025
Filed Apr 16 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $10.9M
41,760 sh across 7 lots
Exec Mar 18 2025
Filed Mar 20 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $2.0M
7,823 sh across 6 lots
Exec Mar 4 2025
Filed Mar 6 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $9.4M
41,760 sh across 6 lots
Exec Feb 4 2025
Filed Feb 6 2025 · 5:30 PM ET More filings →